Presentation

Continued vs Interrupted Oral Anticoagulation During Transfemoral TAVR and Impact of Postop Anticoagulant Management in A-fib Patients

January 09, 2019

REGISTER for free or LOG IN to view this content

Continued vs Interrupted Oral Anticoagulation During Transfemoral TAVR and Impact of Postop Anticoagulant Management in A-fib Patients

Heart Rhythm

Atrial Fibrillation

Factoid

Up Next

Presentation

TAVR in Oncology Patients With Severe AS

January 10, 2019

More slides +

Presentation

Platelet Inhibition With Cangrelor and Crushed Ticagrelor in STEMI Patients Undergoing Primary PCI

January 14, 2019

Presentation

Variation in Use of Manual Aspiration Thrombectomy and Outcomes Following PCI for STEMI

January 15, 2019

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.